Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06139172 · ClinicalTrials.gov registry record · NA

Web Intervention for Parents of Youth With Genetic Syndromes (WINGS)

A NA study of Rett Syndrome and Fragile X Syndrome, sponsored by Rush University Medical Center.

Recruiting
Registry status
NA
Development phase
92
Enrollment target
1
Study location

NCT06139172: Recruiting NA study of Rett Syndrome and Fragile X Syndrome, sponsored by Rush University Medical Center.

NCT06139172 is a NA study of Rett Syndrome and Fragile X Syndrome that is actively recruiting participants, run by Rush University Medical Center. The registered enrollment target is 92 participants, below the 521-participant average among 18 other Rett Syndrome trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06139172, a NA study of Rett Syndrome and Fragile X Syndrome, is actively recruiting participants, sponsored by Rush University Medical Center.

RECRUITING
Registry status
NA
Development phase
92 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the effectiveness of an adapted, telehealth functional behavioral therapy (FBTsIDD) specifically focused on promoting appropriate communication and behavioral strategies in individuals with syndromic intellectual and developmental disorders. Participants will be asked to complete virtual study assessments at intake and then on a monthly basis for the duration of 3-6 months. In addition, participants will attend weekly or biweekly virtual intervention visits with a study therapist.

Primary Outcome

Overall functioning will be measured using the Clinical Global Impression for Severity (CGI-S) and Improvement (CGl-I). GCI-S will be recorded at Baseline with CGI-S and CGI-I collected at all determined visits. The CGI provides a rating of the child's global functioning, taking into account all available information (e.g., child's symptoms, behavior, functioning). The CGI-S and CGl-I will be completed by a blinded independent evaluator.

Conditions Studied

Rett Syndrome Fragile X Syndrome Angelman Syndrome Tuberous Sclerosis Telomeric 22Q13 Monosomy Syndrome Hamartoma Syndrome, Multiple Chromosome 15Q, Partial Deletion Creatine Deficiency, X-linked

Interventions

  • BEHAVIORAL Functional Behavioral Training (FBT)
  • OTHER Positive Parenting Strategies-Treatment as Usual

Study Locations (1)

Illinois

  • Autism Assessment Research Treatment and Services (AARTS) Center at Rush University Medical Center - Chicago

Trial Details

FieldValue
Enrollment Target 92 participants
Start Date 2023-09-15
Est. Completion 2026-12
Phase NA
Rush University Medical Center

320 total trials

What NCT06139172 shows while recruiting

NCT06139172 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 92 participants, a relatively small participant target, below the 521-participant average among 18 other Rett Syndrome trials with a reported enrollment target (82% lower).

The record links to 8 conditions, with Rett Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Functional Behavioral Training (FBT) is the first listed.

NCT06139172 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT06139172 about?

NCT06139172 is a clinical study titled "Web Intervention for Parents of Youth With Genetic Syndromes (WINGS)". The purpose of this study is to evaluate the effectiveness of an adapted, telehealth functional behavioral therapy (FBTsIDD) specifically focused on promoting appropriate communication and behavioral strategies in individuals with syndromic intellectual and developmental disorders. Participants wil...

What is the current status of trial NCT06139172?

This trial is currently recruiting. It is a NA study. The enrollment target is 92 participants. The study started on 2023-09-15. Estimated completion is 2026-12.

What conditions does trial NCT06139172 study?

This clinical trial studies the following conditions: Rett Syndrome, Fragile X Syndrome, Angelman Syndrome, Tuberous Sclerosis, Telomeric 22Q13 Monosomy Syndrome.

What interventions are being tested in trial NCT06139172?

The interventions under investigation include: Functional Behavioral Training (FBT) (BEHAVIORAL), Positive Parenting Strategies-Treatment as Usual (OTHER).

Who is sponsoring clinical trial NCT06139172?

This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06139172 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Rett Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06139172's enrollment target sits among peer trials

92 7th of 18 higher than 12 of 18 other Rett Syndrome trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Rett Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03184545 · 92 participants · Phase 3

    Comparing the Outcome of Electrical Stimulation and Physical Therapy in Patellofemoral Pain Syndrome

  • NCT04172532 · 92 participants · Phase 1

    Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer

  • NCT04508088 · 92 participants

    Skeletal Health and Bone Marrow Composition in Newly Diagnosed Adolescents With Crohn Disease

  • NCT04840602 · 92 participants · Phase 2

    Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06139172

Source: ClinicalTrials.gov NCT06139172, the US trial registry maintained by the National Library of Medicine. NCT06139172 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.